Calcifediol Anhydrous: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Calcifediol Anhydrous. Educational only — not medical advice.
Labeled uses
RAYALDEE is a vitamin D3 analog indicated for the treatment of secondary hyperparathyroidism in adult patients with stage 3 or 4 chronic kidney disease and serum total 25-hydroxyvitamin D levels less than 30 ng/mL. Limitations of Use RAYALDEE is not indicated for the treatment of secondary hyperparathyroidism in patients with stage 5 chronic kidney disease or in patients with end-stage renal disease on dialysis.
Source: FDA labeling via NIH DailyMed (set 6a95effd…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.